Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.
/Abbvie%20Inc%20HQ%20photo-by%20vzphotos%20via%20iStock.jpg)
AbbVie will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.
While one continues reinvesting for growth, the other has rewarded shareholders for 54 years in a row.
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underwriters fully exercised, signaling strong institutional demand....
NORTH CHICAGO, Ill. , July 6, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY ® (epcoritamab) in combination...
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
Analysts are generally favorable when it comes to companies that boast at least a quarter-century of uninterrupted dividend growth, but these are some of their highest-rated names.
NORTH CHICAGO, Ill. , June 29, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging...
NORTH CHICAGO, Ill. , June 29, 2026 /PRNewswire/ --Â AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...